US Patent Issued to NEURACLE SCIENCE on March 11 for "Use of anti-FAM19A5 antibodies for treating atherosclerosis" (South Korean Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,070, issued on March 11, was assigned to NEURACLE SCIENCE Co. LTD. (Seoul, South Korea).

"Use of anti-FAM19A5 antibodies for treating atherosclerosis" was invented by Bongcheol Kim (Seongnam-si, South Korea), Dong Sik Kim (Seoul, South Korea), Jae-Keun Lee (Seoul, South Korea) and Juwon Shim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat an atherosclerosis in a subject in need thereof."

The patent was filed on Dec. 26, 2019, under Application No. 17/418,681.

*...